Variant report

Variant	esv2751126
Chromosome Location	chr12:85912432-86061403
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:911)
CpG islands
(count:122)
Chromatin interactive
region (count:28)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:911 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:86036581-86037005	HepG2	liver:	n/a	n/a
2	ARID3A	chr12:85943398-85943797	HepG2	liver:	n/a	n/a
3	ATF2	chr12:85920866-85921402	GM12878	blood:	n/a	n/a
4	BATF	chr12:85929686-85929979	GM12878	blood:	n/a	n/a
5	BHLHE40	chr12:85925172-85925543	GM12878	blood:	n/a	n/a
6	BRCA1	chr12:86019903-86020631	Hela-S3	cervix:	n/a	n/a
7	CBX3	chr12:86020121-86020665	HCT-116	colon:	n/a	n/a
8	CEBPB	chr12:85948898-85949146	HepG2	liver:	n/a	chr12:85949046-85949057 chr12:85949018-85949029
9	CEBPB	chr12:86036533-86037022	MCF-7	breast:	n/a	chr12:86036746-86036757
10	CEBPB	chr12:86020204-86020533	A549	lung:	n/a	n/a
11	CEBPB	chr12:86020105-86020665	HCT-116	colon:	n/a	chr12:86020651-86020662
12	CEBPB	chr12:86019722-86020633	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr12:85978809-85979116	HepG2	liver:	n/a	chr12:85978973-85978986 chr12:85978973-85978984 chr12:85978975-85978984 chr12:85978974-85978985 chr12:85978973-85978986 chr12:85978975-85978984 chr12:85978975-85978984 chr12:85978973-85978986 chr12:85978975-85978984
14	CEBPB	chr12:85943425-85943748	A549	lung:	n/a	n/a
15	CEBPB	chr12:86036576-86036938	A549	lung:	n/a	chr12:86036746-86036757
16	CEBPB	chr12:85978878-85979088	A549	lung:	n/a	chr12:85978973-85978986 chr12:85978973-85978984 chr12:85978975-85978984 chr12:85978974-85978985 chr12:85978973-85978986 chr12:85978975-85978984 chr12:85978975-85978984 chr12:85978973-85978986 chr12:85978975-85978984
17	CEBPB	chr12:85981944-85982144	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr12:86036542-86036989	Hela-S3	cervix:	n/a	chr12:86036746-86036757
19	CEBPB	chr12:86027250-86027714	HCT-116	colon:	n/a	n/a
20	CEBPB	chr12:86002046-86002376	HepG2	liver:	n/a	n/a
21	CEBPB	chr12:86021300-86021775	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr12:85943405-85943769	HepG2	liver:	n/a	n/a
23	CEBPB	chr12:86036618-86036904	HepG2	liver:	n/a	chr12:86036746-86036757
24	CEBPB	chr12:85916987-85917438	Hela-S3	cervix:	n/a	chr12:85917175-85917188
25	CEBPB	chr12:86036562-86036986	A549	lung:	n/a	chr12:86036746-86036757
26	CEBPB	chr12:86032813-86033108	HepG2	liver:	n/a	chr12:86033071-86033083
27	CEBPB	chr12:86036609-86036880	HepG2	liver:	n/a	chr12:86036746-86036757
28	CEBPB	chr12:86028843-86029069	HepG2	liver:	n/a	n/a
29	CEBPB	chr12:86020158-86020619	A549	lung:	n/a	n/a
30	CEBPB	chr12:85981876-85982197	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr12:86036612-86036933	H1-hESC	embryonic stem cell:	n/a	chr12:86036746-86036757
32	CEBPB	chr12:86002098-86002319	A549	lung:	n/a	n/a
33	CEBPB	chr12:86036545-86036953	IMR90	lung:	n/a	chr12:86036746-86036757
34	CEBPB	chr12:86060080-86060137	HepG2	liver:	n/a	n/a
35	CEBPB	chr12:86036541-86036964	HepG2	liver:	n/a	chr12:86036746-86036757
36	CEBPB	chr12:85942491-85942784	A549	lung:	n/a	n/a
37	CEBPB	chr12:85948894-85949140	A549	lung:	n/a	chr12:85949046-85949057 chr12:85949018-85949029
38	CEBPB	chr12:86019830-86021039	IMR90	lung:	n/a	chr12:86020651-86020662
39	CEBPB	chr12:85942503-85942765	H1-hESC	embryonic stem cell:	n/a	n/a
40	CEBPB	chr12:86036563-86036936	MCF-7	breast:	n/a	chr12:86036746-86036757
41	CEBPB	chr12:86036559-86036960	HepG2	liver:	n/a	chr12:86036746-86036757
42	CEBPB	chr12:86052168-86052249	K562	blood:	n/a	n/a
43	CEBPB	chr12:85957585-85957738	Hela-S3	cervix:	n/a	chr12:85957676-85957689 chr12:85957676-85957689 chr12:85957676-85957687 chr12:85957676-85957689 chr12:85957676-85957687
44	CEBPB	chr12:85942473-85942800	HepG2	liver:	n/a	n/a
45	CEBPB	chr12:85966835-85967062	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr12:86020007-86020716	HCT-116	colon:	n/a	chr12:86020651-86020662
47	CEBPB	chr12:86021336-86021743	IMR90	lung:	n/a	n/a
48	CEBPB	chr12:86036462-86037083	HCT-116	colon:	n/a	chr12:86036746-86036757
49	CEBPB	chr12:85942408-85942794	A549	lung:	n/a	chr12:85942416-85942428
50	CEBPB	chr12:86052095-86052295	Hela-S3	cervix:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:85945089-85945139	SK-N-SH	brain:	n/a
2	chr12:86040467-86040517	AG09319	gingival:	n/a
3	chr12:86040467-86040517	HIPEpiC	eye:	n/a
4	chr12:85945089-85945139	HIPEpiC	eye:	n/a
5	chr12:86040467-86040517	PrEC	prostate:	n/a
6	chr12:86040467-86040517	SK-N-MC	brain:	n/a
7	chr12:86040467-86040517	PANC-1	pancreas:	n/a
8	chr12:85945089-85945139	NB4	blood:	n/a
9	chr12:86040467-86040517	GM06990	blood:	n/a
10	chr12:85945089-85945139	NT2-D1	testis:	n/a
11	chr12:86040467-86040517	BE2_C	brain:	n/a
12	chr12:85945089-85945139	HCF	heart:	n/a
13	chr12:85945089-85945139	NHBE	bronchial:	n/a
14	chr12:85945089-85945139	H1-hESC	embryonic stem cell:	embryo
15	chr12:86040467-86040517	ECC-1	luminal epithelium:	n/a
16	chr12:85945089-85945139	T-47D	breast:	n/a
17	chr12:85945089-85945139	AG10803	skin:	n/a
18	chr12:86040467-86040517	HEEpiC	esophagus:	n/a
19	chr12:86040467-86040517	HL-60	blood:	n/a
20	chr12:86040467-86040517	NB4	blood:	n/a
21	chr12:85945089-85945139	HCM	heart:	n/a
22	chr12:86040467-86040517	HCT-116	colon:	n/a
23	chr12:85945089-85945139	RPTEC	kidney:	n/a
24	chr12:86040467-86040517	GM12878	blood:	n/a
25	chr12:85945089-85945139	ECC-1	luminal epithelium:	n/a
26	chr12:86040467-86040517	AG09309	skin:	n/a
27	chr12:86040467-86040517	PFSK-1	brain:	n/a
28	chr12:85945089-85945139	AG04449	skin:	fetal
29	chr12:86040467-86040517	HRE	kidney:	n/a
30	chr12:86040467-86040517	SKMC	muscle:	n/a
31	chr12:85945089-85945139	Hepatocyte	liver:	n/a
32	chr12:85945089-85945139	HCT-116	colon:	n/a
33	chr12:85945089-85945139	IMR90	lung:	fetal
34	chr12:85945089-85945139	SK-N-MC	brain:	n/a
35	chr12:85945089-85945139	HepG2	liver:	n/a
36	chr12:86040467-86040517	HPAEpiC	pulmonary alveolar:	n/a
37	chr12:85945089-85945139	Caco-2	colon:	n/a
38	chr12:86040467-86040517	Caco-2	colon:	n/a
39	chr12:85945089-85945139	BJ	skin:	n/a
40	chr12:85945089-85945139	ovcar-3	ovarian:	n/a
41	chr12:85945089-85945139	HRCEpiC	kidney:	n/a
42	chr12:85945089-85945139	MCF-7	breast:	n/a
43	chr12:86040467-86040517	CMK	blood:	n/a
44	chr12:86040467-86040517	NT2-D1	testis:	n/a
45	chr12:85945089-85945139	MCF10A-Er-Src	breast:	n/a
46	chr12:86040467-86040517	SK-N-SH	brain:	n/a
47	chr12:86040467-86040517	H1-hESC	embryonic stem cell:	embryo
48	chr12:85945089-85945139	BE2_C	brain:	n/a
49	chr12:85945089-85945139	GM12878	blood:	n/a
50	chr12:85945089-85945139	HAEpiC	amniotic membrane:	n/a

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:85908005..85909863-chr12:85911172..85913825,2	MCF-7	breast:
2	chr12:86002253..86004144-chr12:86006143..86008700,2	MCF-7	breast:
3	chr12:85930199..85932678-chr12:85934950..85937006,2	K562	blood:
4	chr12:85972231..85974209-chr12:85975781..85977996,2	MCF-7	breast:
5	chr12:85940120..85942691-chr12:85944053..85946791,2	MCF-7	breast:
6	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:
7	chr12:85968890..85970646-chr12:86260113..86261752,8	MCF-7	breast:
8	chr12:85916869..85918658-chr12:85921402..85924342,2	K562	blood:
9	chr12:85940120..85942691-chr12:85944053..85946791,2	MCF-7	breast:
10	chr12:85949711..85951775-chr12:85954587..85956542,2	K562	blood:
11	chr12:85969245..85970171-chr12:86260729..86261622,3	MCF-7	breast:
12	chr12:85969213..85970141-chr12:86036344..86037184,4	MCF-7	breast:
13	chr12:86014804..86017595-chr12:86018520..86021053,2	MCF-7	breast:
14	chr12:86008021..86010789-chr12:86012957..86015625,2	MCF-7	breast:
15	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:
16	chr12:85972333..85972969-chr12:86260657..86261419,2	MCF-7	breast:
17	chr12:85969213..85970141-chr12:86036344..86037184,4	MCF-7	breast:
18	chr12:85916869..85918658-chr12:85921402..85924342,2	K562	blood:
19	chr12:86014804..86017595-chr12:86018520..86021053,2	MCF-7	breast:
20	chr12:86036224..86038282-chr12:86040678..86042966,2	MCF-7	breast:
21	chr12:86039752..86042569-chr12:86049192..86051489,2	MCF-7	breast:
22	chr12:85930199..85932678-chr12:85934950..85937006,2	K562	blood:
23	chr12:85956037..85957820-chr12:85959579..85961160,2	K562	blood:
24	chr12:86002253..86004144-chr12:86006143..86008700,2	MCF-7	breast:
25	chr12:85972231..85974209-chr12:85975781..85977996,2	MCF-7	breast:
26	chr12:85956037..85957820-chr12:85959579..85961160,2	K562	blood:
27	chr12:85949711..85951775-chr12:85954587..85956542,2	K562	blood:
28	chr12:86008021..86010789-chr12:86012957..86015625,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ALX1-2	chr12:85988245-85988373	NONHSAT029750

No data

Variant related genes	Relation type
ENSG00000257855	TF binding region
ENSG00000263449	TF binding region
ENSG00000257855	CpG island
ENSG00000263449	CpG island
ENSG00000263449	chromatin interactions

Extended variants
information (count: 3523 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:3523 , 50 per page) page: 1 2 3 4 5 6 7 ... 71

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7961629	chr12:85912432-85912433	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs567527540	chr12:85912439-85912440	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs544111969	chr12:85912454-85912455	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs189688058	chr12:85912455-85912456	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs150830716	chr12:85912459-85912460	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs180820807	chr12:85912491-85912492	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs183768813	chr12:85912540-85912541	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs57059247	chr12:85912600-85912601	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs188200998	chr12:85912603-85912604	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs574812948	chr12:85912618-85912619	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs573351344	chr12:85912619-85912620	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs540378558	chr12:85912631-85912632	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs561953716	chr12:85912639-85912640	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs573959488	chr12:85912648-85912649	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs181738179	chr12:85912729-85912730	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs560076781	chr12:85912757-85912758	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs56193328	chr12:85912804-85912805	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs140215217	chr12:85912806-85912807	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs527724568	chr12:85912868-85912869	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs533405625	chr12:85912893-85912894	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs551581684	chr12:85912917-85912918	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs138172601	chr12:85912931-85912932	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs142862471	chr12:85912932-85912933	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs549166693	chr12:85912955-85912956	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs77237840	chr12:85912970-85912971	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs61602821	chr12:85912985-85912986	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs146089686	chr12:85913009-85913010	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs75873662	chr12:85913015-85913016	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs397696561	chr12:85913017-85913018	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs571144513	chr12:85913073-85913074	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550078972	chr12:85913090-85913091	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs191695815	chr12:85913109-85913110	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs369472543	chr12:85913119-85913120	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs565283826	chr12:85913125-85913126	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs565726215	chr12:85913132-85913133	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs10779164	chr12:85913178-85913179	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs547008872	chr12:85913253-85913254	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs181861021	chr12:85913262-85913263	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs60691668	chr12:85913359-85913360	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs544494104	chr12:85913376-85913377	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs556862938	chr12:85913445-85913446	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs186427418	chr12:85913498-85913499	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs545346882	chr12:85913503-85913504	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs140155539	chr12:85913593-85913594	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs191375588	chr12:85913617-85913618	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs182706191	chr12:85913664-85913665	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs561051349	chr12:85913698-85913699	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs149819809	chr12:85913705-85913706	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs549801299	chr12:85913723-85913724	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs571470237	chr12:85913746-85913747	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17899364	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	22032731	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Renal cell carcinoma	18194544	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:381 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:85910000-85913000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr12:85911000-85912600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr12:85911400-85912800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr12:85912200-85912800	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr12:85912200-85913800	Enhancers	HUES6 Cell Line	embryonic stem cell
6	chr12:85912200-85913800	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr12:85912200-85913800	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr12:85912400-85912600	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr12:85912400-85912800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
10	chr12:85912400-85913200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr12:85912400-85913200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr12:85912400-85914000	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr12:85912600-85913000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
14	chr12:85912600-85913800	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr12:85912800-85913000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
16	chr12:85912800-85913200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr12:85913000-85913200	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr12:85913000-85913400	Enhancers	H1 Cell Line	embryonic stem cell
19	chr12:85913000-85913400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr12:85913000-85913800	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr12:85913200-85913400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
22	chr12:85913200-85913600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr12:85913400-85913800	Enhancers	HUES48 Cell Line	embryonic stem cell
24	chr12:85916200-85916800	Enhancers	GM12878-XiMat	blood
25	chr12:85916800-85920200	Weak transcription	GM12878-XiMat	blood
26	chr12:85920200-85920600	Enhancers	GM12878-XiMat	blood
27	chr12:85920400-85921800	Enhancers	Primary B cells from peripheral blood	blood
28	chr12:85920600-85921800	Flanking Active TSS	GM12878-XiMat	blood
29	chr12:85920800-85921600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr12:85920800-85921600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr12:85920800-85922400	Enhancers	Primary hematopoietic stem cells	blood
32	chr12:85921000-85921600	Enhancers	ES-I3 Cell Line	embryonic stem cell
33	chr12:85921200-85921400	Enhancers	H1 Cell Line	embryonic stem cell
34	chr12:85921200-85921400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr12:85921200-85921400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr12:85921200-85921600	Enhancers	H9 Cell Line	embryonic stem cell
37	chr12:85921200-85921600	Enhancers	Primary hematopoietic stem cells short term culture	blood
38	chr12:85921200-85921600	Enhancers	Fetal Thymus	thymus
39	chr12:85921400-85922200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr12:85921400-85924200	Weak transcription	H1 Cell Line	embryonic stem cell
41	chr12:85921400-85925200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr12:85921600-85926200	Enhancers	Fetal Intestine Small	intestine
43	chr12:85921800-85922600	Enhancers	GM12878-XiMat	blood
44	chr12:85922200-85922400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr12:85922400-85924000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
46	chr12:85922400-85924200	Weak transcription	Primary hematopoietic stem cells	blood
47	chr12:85922600-85924000	Weak transcription	GM12878-XiMat	blood
48	chr12:85923200-85923400	Enhancers	Duodenum Mucosa	Duodenum
49	chr12:85923200-85926200	Enhancers	Fetal Intestine Large	intestine
50	chr12:85924000-85924200	Active TSS	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links